Wikidata

(Q49903927)

English

Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.

scientific article published on 14 February 2018

In more languages

Statements

title
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29454091
retrieved
23 February 2018
reference URL
http://europepmc.org/abstract/MED/29454091

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q49903927&oldid=1071164160"